US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.21

-0.1050-4.54%

Post-market: 2.310.0999+4.52%18:24 EDT

Volume:160.94K

Turnover:362.85K

Market Cap:63.79M

PE:-1.43

High:2.36

Open:2.29

Low:2.18

Close:2.32

Loading ...

Overview Company News Filings

Vistagen Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview

Press Release: Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025

VistaGen Therapeutics Inc. to Announce Fiscal Year 2025 Financial Results

Vistagen Therapeutics Inc expected to post a loss of 50 cents a share - Earnings Preview

BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial

Vistagen Therapeutics Inc - Palisade-4 Phase 3 Trial Results Expected in First Half of 2026

THOMSON REUTERS

Vistagen on Track to Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year

THOMSON REUTERS

VistaGen Therapeutics to Present at Jefferies 2025 Global Life Sciences Conference in New York

VistaGen Therapeutics Inc. to Present New Insights at the American Society of Clinical Psychopharmacology Conference

Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference

Vistagen to Present at the 2025 Anxiety and Depression Association Conference

Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ...

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates

Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate

Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update

Vistagen Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview

Vistagen Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VTGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":2.21,"timestamp":1749844800000,"preClose":2.315,"halted":0,"volume":160944,"hourTrading":{"tag":"盘后","latestPrice":2.3099,"preClose":2.21,"latestTime":"18:24 EDT","volume":583,"amount":1343.6925,"timestamp":1749853448635},"delay":0,"floatShares":20190232,"shares":28862085,"eps":-1.54687,"marketStatus":"Market Closed","change":-0.105,"latestTime":"06-13 16:00:00 EDT","open":2.29,"high":2.36,"low":2.18,"amount":362850.7265376,"amplitude":0.077754,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.54687,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":2.315,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.315,"latestTime":"09:24 EDT","volume":11,"amount":26.330001499999998,"timestamp":1749821081024},"postHourTrading":{"tag":"盘后","latestPrice":2.3099,"preClose":2.21,"latestTime":"18:24 EDT","volume":583,"amount":1343.6925,"timestamp":1749853448635},"volumeRatio":1.1391152562553473,"impliedVol":4.12,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":20190232,"roa":"-29.57%","roe":"-46.28%","lyrEps":-1.517063,"volumeRatio":1.1391152562553473,"shares":28862085,"dividePrice":0,"high":2.36,"amplitude":0.077754,"preClose":2.315,"low":2.18,"week52Low":1.9,"pbRate":"0.79","psRate":"91.38","week52High":4.21,"institutionHeld":0,"latestPrice":2.21,"eps":-1.54687,"divideRate":0,"volume":160944,"delay":0,"ttmEps":-1.54687,"open":2.29,"prevYearClose":2.95,"prevWeekClose":2.36,"prevMonthClose":2.58,"prevQuarterClose":2.5,"fiveDayClose":2.36,"twentyDayClose":2.3,"sixtyDayClose":2.72,"earningDate":1750089600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543374186","title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2543374186","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543374186?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:10","pubTimestamp":1749845407,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of50cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a rise in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nL8N3SG217:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2542417511","title":"Press Release: Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542417511","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542417511?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:32","pubTimestamp":1749731520,"startTime":"0","endTime":"0","summary":"Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Tuesday, June 17, 2025, at 2:00 p.m. Pacific Time  to report results for its fiscal year 2025 ended March 31, 2025, and provide a corporate update.The conference call is being webcast live, and a link can be found under \"Events\" in the Investors section of the Company's website. Participants may register to join the live call by following the link here to receive the dial-in numbers and unique PIN to access the call. Those who plan on participating are advised to join 15 minutes prior to the start time. A webcast replay of the call will be available on Vistagen's website about 24 hours after the end of the live conference call and will be accessible for at least 30 days.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","VTGN","BK4139","BK4585","BK4181","HST","BK4588"],"gpt_icon":0},{"id":"2542511156","title":"VistaGen Therapeutics Inc. to Announce Fiscal Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2542511156","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542511156?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:30","pubTimestamp":1749731414,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will report its fiscal year 2025 financial results on June 17, 2025. The results will be released via a conference call and webcast at 2:00 p.m. Pacific Time . Participants can register to join the live call by following the link to receive the dial-in numbers and unique PIN to access the call. A webcast replay will be available on Vistagen's website about 24 hours after the live conference call and will be accessible for at least 30 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL8Q5STP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2541898448","title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2541898448","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541898448?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:12","pubTimestamp":1749240726,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of50cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a rise in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nL5N3S91F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vistagen Therapeutics Inc  expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2540284798","title":"BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540284798","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540284798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:35","pubTimestamp":1748867754,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen On Track To Deliver Topline Data From Fasedienol Palisade-3 Phase 3 TrialJune 2 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN ON TRACK TO DELIVER TOPLINE DATA FROM FASEDIENOL PA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUABK56ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2540981447","title":"Vistagen Therapeutics Inc - Palisade-4 Phase 3 Trial Results Expected in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2540981447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540981447?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:30","pubTimestamp":1748867400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUABK56ZT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2540973798","title":"Vistagen on Track to Deliver Topline Data From Fasedienol Palisade-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2540973798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540973798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:30","pubTimestamp":1748867400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUABK56ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2538476865","title":"VistaGen Therapeutics to Present at Jefferies 2025 Global Life Sciences Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2538476865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538476865?lang=en_us&edition=fundamental","pubTime":"2025-05-28 20:30","pubTimestamp":1748435457,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc., a late clinical-stage biopharmaceutical company, is set to present at the Jefferies 2025 Global Life Sciences Conference in New York. The company's President and CEO, Shawn Singh, will participate in a fireside chat on Thursday, June 5, at 11:40 a.m. Eastern Time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL9QcHGw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2537139619","title":"VistaGen Therapeutics Inc. to Present New Insights at the American Society of Clinical Psychopharmacology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2537139619","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537139619?lang=en_us&edition=fundamental","pubTime":"2025-05-23 20:30","pubTimestamp":1748003428,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will present at the American Society of Clinical Psychopharmacology Conference in Scottsdale, Arizona, from May 27-30, 2025. The company will showcase poster presentations exploring the age of onset of social anxiety disorder from fasedienol clinical trials and the impact of itruvone on nasal chemosensory receptors and the olfactory bulb, which are biomarkers of its effect on nasal chemosensory neurons and olfactory bulb activation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL9VZTBW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2528971440","title":"Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2528971440","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528971440?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"New Data Build on Recent Epidemiology Findings Presented by the Company at the 2024 Neuroscience Education Institute Congress. The Need for Improved Diagnosis and Treatment Options Underscored by Data Presented in Posters. \"This new research provides a clearer and more comprehensive picture of social anxiety disorder — shining light on its rising prevalence and significant impact on young adults,\" said Ross Baker, Ph.D., MBA, Vice President, Medical Strategy at Vistagen and a co-author of the research. \"Existing therapies remain limited, and these findings reinforce the urgent need for new treatment options. The new research also highlights the critical role of timely diagnosis to improve patient outcomes.\". The key findings from the poster presentations by Vistagen at the ADAA and NEI conferences reveal important insights into SAD, including:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-presents-research-impact-social-123000130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VTGN"],"gpt_icon":1},{"id":"2520518145","title":"Vistagen to Present at the 2025 Anxiety and Depression Association Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2520518145","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520518145?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387400,"startTime":"0","endTime":"0","summary":"Posters Highlight New Insights into Social Anxiety Disorder. SOUTH SAN FRANCISCO, Calif., March 19, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will present at the Anxiety and Depression Association of America  Conference in Las Vegas, Nevada from April 3 to 5, 2025. The Company’s poster presentations will explore the age of onset of social anxiety disorder  from participants in fasedienol clinical trials, and new data on the characteristics of young adults with and without SAD.Date: Saturday, April 5, 2025, 5:00 p.m. Eastern TimeTitle: Social Anxiety Disorder among Young Adults : A Cross-Sectional Study Using Data from the US National Health and Wellness SurveyAuthors: Ross A. Baker, PhD; Josh Prince; Nikoletta Sternbach; Soohyun Hwang, PhD, MPHPoster Number: S109. This press release contains certain f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-present-2025-anxiety-depression-123000467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2516467905","title":"Vistagen to Participate in Stifel 2025 Virtual CNS Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467905","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467905?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., March 04, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced that management will participate in Stifel’s 2025 Virtual CNS Forum.Vistagen’s President and Chief Executive Officer, Shawn Singh, will participate in a fireside chat presentation on Tuesday, March 18, 2025, at 12 p.m. Eastern Time. A live webcast will be accessible through the \"Events\" page in the \"Investors\" section of the Company’s website at www.Vistagen.com. A replay of the webcast will be archived and available following the event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-participate-stifel-2025-virtual-133000498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FET","SF","VTGN","BK4179","BK4135","CNS","BK4127"],"gpt_icon":1},{"id":"2511710946","title":"Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511710946","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511710946?lang=en_us&edition=fundamental","pubTime":"2025-02-15 20:33","pubTimestamp":1739622823,"startTime":"0","endTime":"0","summary":"NasdaqCM:VTGN Earnings and Revenue History February 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 31%. Earnings per share  also surpassed analyst estimates by 9.8%.Looking ahead, revenue is forecast to grow 65% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 5.7% from a week ago.You still need to take note of risks, for example - Vistagen Therapeutics has   3 warning signs    we think you should know about.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-third-quarter-2025-123343743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","VTGN"],"gpt_icon":0},{"id":"2511809653","title":"Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511809653","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511809653?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:22","pubTimestamp":1739517748,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Vistagen Therapeutics Inc  reported positive results from their Palisade 2 Phase 3 trial for the acute treatment of social anxiety disorder  with their lead product candidate, fasinol.The company has initiated Palisade 3 and Palisade 4 Phase 3 trials, which are advancing towards expected top-line results later this year.Vistagen has a strong cash position with $88.6 million in cash equivalents and marketable securities as of December 31, 2024, providing financial stability for ongoing research and development.A: Sean Singh, CEO: There is a robust market in the U.S. with over 30 million adults affected by social anxiety disorder. Our approach is unique, relying on nose-to-brain neu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-inc-vtgn-q3-072228859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN"],"gpt_icon":0},{"id":"2511504178","title":"VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2511504178","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511504178?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:55","pubTimestamp":1739487305,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics, Inc.  came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8%. A quarter ago, it was expected that this company would post a loss of $0.40 per share when it actually produced a loss of $0.42, delivering a surprise of -5%.VistaGen Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.23 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 35%. This compares to year-ago revenues of $0.41 million. The company has not been able to beat consensus revenue estimates over the last four quarters.VistaGen Therapeutics shares have lost about 7.1% since the beginning of the year versus the S&P 500's gain of 2.9%.While VistaGen Therapeutics has underperformed the market so far this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-inc-vtgn-reports-225505166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN"],"gpt_icon":0},{"id":"2511503697","title":"Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2511503697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511503697?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:02","pubTimestamp":1739484133,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryVistagen Therapeutics Inc VTGN.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nL8N3P4316:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2511650866","title":"VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2511650866","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511650866?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:42","pubTimestamp":1739482939,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 109.09 percent decrease over losses of $(0.22) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43714278/vistagen-therapeutics-q3-eps-0-46-beats-0-51-estimate-sales-234-00k-beat-180-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":1},{"id":"2511081825","title":"Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2511081825","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511081825?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:30","pubTimestamp":1739482200,"startTime":"0","endTime":"0","summary":"Fasedienol U.S. registration-directed PALISADE Phase 3 Program for acute treatment of social anxiety disorder progressing with ongoing PALISADE-3, PALISADE-4 and Repeat Dose trials. Vistagen highlights clinical-stage pipeline with five novel pherine product candidates with positive efficacy signals and potential to transform standards of care for multiple high prevalence indications. SOUTH SAN FRANCISCO, Calif., February 13, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today reported financial results for its fiscal year 2025 third quarter ended December 31, 2024, and provided a corporate update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-reports-fiscal-2025-third-213000688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2510350945","title":"Vistagen Therapeutics Inc  expected to post a loss of 51 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2510350945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510350945?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:34","pubTimestamp":1739309646,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of51cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL8N3P22N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2509719384","title":"Vistagen Therapeutics Inc  expected to post a loss of 51 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2509719384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509719384?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:07","pubTimestamp":1738926428,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of51cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL8N3OY0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"VTGN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.53,"defaultRemindTime":1750190400000,"name":null,"time":"Post Market","dateTimestamp":1750132800000,"actualEps":null},{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-11-07","symbol":"VTGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-13","symbol":"VTGN","fiscalQuarterEnding":"2024/06","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2024-06-11","symbol":"VTGN","fiscalQuarterEnding":"2024/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1718078400000,"reportTimeType":"post","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1701921600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2025-06-13","current":-1.412475,"percent":0.727421,"low":-37.785134,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"high":-0.195082,"avg":-6.982118,"sd":9.175904,"marketCap":66815726},"quantilePoints":[{"date":"2020-06-19","current":-1.101489,"twenty":-2.184898,"median":-1.463217,"eighty":-0.742724,"marketCap":25588252},{"date":"2020-06-26","current":-1.115892,"twenty":-2.179626,"median":-1.44825,"eighty":-0.742724,"marketCap":25922837},{"date":"2020-07-02","current":-1.42562,"twenty":-2.173272,"median":-1.445801,"eighty":-0.742724,"marketCap":29615825},{"date":"2020-07-10","current":-1.297287,"twenty":-2.167921,"median":-1.438446,"eighty":-0.742724,"marketCap":26949843},{"date":"2020-07-17","current":-1.570598,"twenty":-2.154905,"median":-1.438446,"eighty":-0.742724,"marketCap":32627603},{"date":"2020-07-24","current":-2.05359,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":42661289},{"date":"2020-07-31","current":-2.514134,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":52228620},{"date":"2020-08-07","current":-3.089651,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":64184406},{"date":"2020-08-14","current":-3.162221,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":55942531},{"date":"2020-08-21","current":-2.87737,"twenty":-2.145804,"median":-1.438446,"eighty":-0.742724,"marketCap":50903263},{"date":"2020-08-28","current":-2.887409,"twenty":-2.152145,"median":-1.438446,"eighty":-0.742724,"marketCap":51080858},{"date":"2020-09-04","current":-2.541907,"twenty":-2.160117,"median":-1.438446,"eighty":-0.742724,"marketCap":44968619},{"date":"2020-09-11","current":-2.562821,"twenty":-2.168669,"median":-1.438446,"eighty":-0.742724,"marketCap":45338609},{"date":"2020-09-18","current":-2.695417,"twenty":-2.17444,"median":-1.438446,"eighty":-0.742724,"marketCap":47684347},{"date":"2020-09-25","current":-2.57286,"twenty":-2.180777,"median":-1.438446,"eighty":-0.742724,"marketCap":45516204},{"date":"2020-10-02","current":-3.061833,"twenty":-2.188503,"median":-1.438446,"eighty":-0.742724,"marketCap":54166577},{"date":"2020-10-09","current":-3.11621,"twenty":-2.200038,"median":-1.438446,"eighty":-0.742724,"marketCap":55128552},{"date":"2020-10-16","current":-3.413609,"twenty":-2.205567,"median":-1.438446,"eighty":-0.742724,"marketCap":60389814},{"date":"2020-10-23","current":-3.281431,"twenty":-2.216002,"median":-1.438446,"eighty":-0.742724,"marketCap":58051475},{"date":"2020-10-30","current":-2.992398,"twenty":-2.228727,"median":-1.438446,"eighty":-0.742724,"marketCap":52938209},{"date":"2020-11-06","current":-2.823411,"twenty":-2.235372,"median":-1.440595,"eighty":-0.742724,"marketCap":49948688},{"date":"2020-11-13","current":-3.309225,"twenty":-2.243769,"median":-1.447362,"eighty":-0.742724,"marketCap":51798639},{"date":"2020-11-20","current":-3.358391,"twenty":-2.251548,"median":-1.461665,"eighty":-0.742724,"marketCap":52568219},{"date":"2020-11-27","current":-3.640148,"twenty":-2.258433,"median":-1.467237,"eighty":-0.742724,"marketCap":56978503},{"date":"2020-12-04","current":-3.630693,"twenty":-2.266793,"median":-1.47671,"eighty":-0.742724,"marketCap":56830507},{"date":"2020-12-11","current":-3.474686,"twenty":-2.279445,"median":-1.498443,"eighty":-0.742724,"marketCap":54388571},{"date":"2020-12-18","current":-11.903133,"twenty":-2.291259,"median":-1.520919,"eighty":-0.742724,"marketCap":186317357},{"date":"2020-12-24","current":-12.212852,"twenty":-2.309867,"median":-1.543115,"eighty":-0.742724,"marketCap":191165325},{"date":"2020-12-31","current":-17.084132,"twenty":-2.322388,"median":-1.548046,"eighty":-0.742724,"marketCap":267414498},{"date":"2021-01-08","current":-19.10957,"twenty":-2.333493,"median":-1.548046,"eighty":-0.742724,"marketCap":299118279},{"date":"2021-01-15","current":-21.221638,"twenty":-2.351108,"median":-1.548046,"eighty":-0.742724,"marketCap":332178060},{"date":"2021-01-22","current":-19.541592,"twenty":-2.35963,"median":-1.548046,"eighty":-0.742724,"marketCap":305880630},{"date":"2021-01-29","current":-18.74578,"twenty":-2.377597,"median":-1.548046,"eighty":-0.742724,"marketCap":293423953},{"date":"2021-02-05","current":-17.949969,"twenty":-2.395255,"median":-1.548046,"eighty":-0.742724,"marketCap":280967275},{"date":"2021-02-12","current":-18.054458,"twenty":-2.424455,"median":-1.548046,"eighty":-0.742724,"marketCap":270636328},{"date":"2021-02-19","current":-27.979684,"twenty":-2.444135,"median":-1.559823,"eighty":-0.742724,"marketCap":419415462},{"date":"2021-02-26","current":-23.347912,"twenty":-2.449711,"median":-1.559823,"eighty":-0.742724,"marketCap":349985200},{"date":"2021-03-05","current":-20.134029,"twenty":-2.470472,"median":-1.558206,"eighty":-0.742674,"marketCap":301809099},{"date":"2021-03-12","current":-22.2136,"twenty":-2.499151,"median":-1.561745,"eighty":-0.742674,"marketCap":332981870},{"date":"2021-03-19","current":-22.471645,"twenty":-2.519736,"median":-1.561745,"eighty":-0.742674,"marketCap":336849963},{"date":"2021-03-26","current":-20.559165,"twenty":-2.555481,"median":-1.563666,"eighty":-0.742724,"marketCap":308181881},{"date":"2021-04-01","current":-20.941661,"twenty":-2.570852,"median":-1.563666,"eighty":-0.742724,"marketCap":313915497},{"date":"2021-04-09","current":-20.654789,"twenty":-2.606601,"median":-1.561745,"eighty":-0.742674,"marketCap":309615285},{"date":"2021-04-16","current":-19.602925,"twenty":-2.636028,"median":-1.561745,"eighty":-0.742674,"marketCap":293847840},{"date":"2021-04-23","current":-19.507301,"twenty":-2.644829,"median":-1.561745,"eighty":-0.742674,"marketCap":292414436},{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726}],"updateTime":1749936654109}}}